Latest filing published 27 Feb 2026 for Avidity Biosciences, Inc.. Read the official filing
No signal scores available.
All filings by Jean Jinsun Kim on record concern Avidity Biosciences, Inc. The record holds 2 filings, for trades running from 10 June 2025 to 27 February 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 27 February 2026, the filings show a transaction in Avidity Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations